ForSight Labs, an incubator for opthalmic and eye care startups, has taken in $12 million for its third company, ForSight Vision3, a stealthy developer of technology for eye care, reports VentureWire. Based in Menlo Park, Calif., the company didn't even list investors in the round on its filing -- although Morgenthaler Ventures, Split Rock Partners and Versant Ventures are all represented on its board of directors. Last year, these firms provided a $6 million first round of funding for Vision3.
ForSight Labs was spun out of The Foundry in 2005 to support early-stage opthalmic device makers. Since then, it has founded two companies -- Transcend Medical, which raised $9.4 million in capital, and drug delivery plug maker Newco II, which raised $5 million and was acquired in 2006 by QLT for $42 million.